このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

ImExHS 将来の成長

Future 基準チェック /26

ImExHSは収益が増加すると予測されています。

主要情報

n/a

収益成長率

n/a

EPS成長率

Healthcare Services 収益成長	24.1%
収益成長率	20.2%
将来の株主資本利益率	0.3%
アナリストカバレッジ	Low
最終更新日	03 Mar 2024

今後の成長に関する最新情報

Recent updates

Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet

Jan 02

業績と収益の成長予測

ASX:IME - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	37	N/A	N/A	8	1
12/31/2025	31	N/A	N/A	5	1
12/31/2024	24	N/A	N/A	5	1
12/31/2023	20	-4	0	3	N/A
9/30/2023	18	-4	0	2	N/A
6/30/2023	17	-4	-1	1	N/A
3/31/2023	17	-3	-3	-1	N/A
12/31/2022	17	-3	-4	-2	N/A
9/30/2022	18	-3	-5	-2	N/A
6/30/2022	18	-4	-5	-3	N/A
3/31/2022	16	-4	-5	-3	N/A
12/31/2021	13	-5	-6	-3	N/A
9/30/2021	13	-4	-5	-2	N/A
6/30/2021	12	-4	-4	-2	N/A
3/31/2021	11	-4	-4	-2	N/A
12/31/2020	11	-4	-4	-1	N/A
9/30/2020	10	-5	-5	-3	N/A
6/30/2020	10	-6	-6	-4	N/A
3/31/2020	9	-6	-6	-4	N/A
12/31/2019	8	-6	-7	-4	N/A
9/30/2019	7	-6	-6	-3	N/A
6/30/2019	7	-7	-5	-3	N/A
3/31/2019	6	-6	-4	-2	N/A
12/31/2018	6	-5	-3	-2	N/A
9/30/2018	5	-3	-3	-1	N/A
6/30/2018	4	-1	-2	-1	N/A
3/31/2018	4	-1	-1	-1	N/A
12/31/2017	4	-1	0	0	N/A
12/31/2016	3	0	N/A	0	N/A
12/31/2015	4	0	N/A	N/A	N/A

アナリストによる今後の成長予測

収入対貯蓄率: IMEの予測収益成長が貯蓄率 ( 2.3% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: IMEの収益がAustralian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: IMEの収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: IMEの収益 ( 20.2% ) Australian市場 ( 5.4% ) よりも速いペースで成長すると予測されています。

高い収益成長: IMEの収益 ( 20.2% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: IMEの自己資本利益率は、3年後には低くなると予測されています ( 0.3 %)。

ImExHS 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Price target decreased by 18% to AU$1.50

ImExHS Limited Provides Revenue Guidance for the Second Half and Full Year of 2023

Price target decreased by 10% to AU$1.82

Price target decreased to AU$2.03

ImExHS Limited Revises Earnings Guidance for the Fiscal Year 2022

Consensus forecasts updated

Recent updates

ImExHS Limited, Annual General Meeting, Apr 23, 2024

ImExHS Limited has completed a Follow-on Equity Offering in the amount of AUD 1.5 million.

Full year 2023 earnings released: AU$0.10 loss per share (vs AU$0.085 loss in FY 2022)

Price target decreased by 18% to AU$1.50

ImExHS Limited to Report Fiscal Year 2023 Results on Feb 29, 2024

Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet

First half 2023 earnings released: AU$0.055 loss per share (vs AU$0.053 loss in 1H 2022)

ImExHS Limited Provides Revenue Guidance for the Second Half and Full Year of 2023

New minor risk - Financial data availability

New major risk - Revenue and earnings growth

New minor risk - Share price stability

ImExHS Limited (ASX:IME) Screens Well But There Might Be A Catch

Full year 2022 earnings released: AU$0.085 loss per share (vs AU$0.15 loss in FY 2021)

Price target decreased by 10% to AU$1.82

Less than half of directors are independent

Price target decreased to AU$2.03

ImExHS Limited has completed a Follow-on Equity Offering in the amount of AUD 1.975112 million.

First half 2022 earnings released: AU$0.053 loss per share (vs AU$0.092 loss in 1H 2021)

ImExHS Limited to Report First Half, 2022 Results on Aug 30, 2022

ImExHS Limited Revises Earnings Guidance for the Fiscal Year 2022

Consensus forecasts updated

Less than half of directors are independent

Is ImExHS (ASX:IME) Using Too Much Debt?

Full year 2021 earnings: EPS exceeds analyst expectations

ImExHS Limited, Annual General Meeting, May 19, 2022

ImExHS Limited to Report Fiscal Year 2021 Results on Feb 28, 2022

IMEXHS Launches Aquila in the Thai Market

Consensus revenue estimates fall by 11%

ImExHS Limited Provides Consolidated Revenue Guidance for the Fiscal Year 2021

Non-Executive Chairman recently bought AU$64k worth of stock

Independent Non-Executive Director recently bought AU$59k worth of stock

Price target decreased to AU$2.48

Independent Non-Executive Director recently bought AU$99k worth of stock

Full year 2020 earnings released: AU$0.15 loss per share (vs AU$0.31 loss in FY 2019)

Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)

Independent Non-Executive Director recently bought AU$173k worth of stock

Full year 2020 earnings released: AU$0.15 loss per share (vs AU$0.32 loss in FY 2019)

ImExHS Limited to Report Fiscal Year 2020 Results on Feb 26, 2021

Did You Miss ImExHS' (ASX:IME) 60% Share Price Gain?

New 90-day high: AU$2.00

Imexhs Limited Announces Executive Changes

Independent Non-Executive Director recently bought AU$58k worth of stock

First half earnings released

ImExHS Limited announced that it expects to receive AUD 0.5 million in funding from Domatorisaro Pty Ltd

Independent Non-Executive Director recently bought AU$51k worth of stock

ImExHS Limited to Report First Half, 2020 Results on Aug 31, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘